Cell-cell coupling and DNA methylation abnormal phenotypes in the after-hours mice.
Journal
Epigenetics & chromatin
ISSN: 1756-8935
Titre abrégé: Epigenetics Chromatin
Pays: England
ID NLM: 101471619
Informations de publication
Date de publication:
06 01 2021
06 01 2021
Historique:
received:
05
07
2020
accepted:
13
11
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
14
1
2022
Statut:
epublish
Résumé
DNA methylation has emerged as an important epigenetic regulator of brain processes, including circadian rhythms. However, how DNA methylation intervenes between environmental signals, such as light entrainment, and the transcriptional and translational molecular mechanisms of the cellular clock is currently unknown. Here, we studied the after-hours mice, which have a point mutation in the Fbxl3 gene and a lengthened circadian period. In this study, we used a combination of in vivo, ex vivo and in vitro approaches. We measured retinal responses in Afh animals and we have run reduced representation bisulphite sequencing (RRBS), pyrosequencing and gene expression analysis in a variety of brain tissues ex vivo. In vitro, we used primary neuronal cultures combined to micro electrode array (MEA) technology and gene expression. We observed functional impairments in mutant neuronal networks, and a reduction in the retinal responses to light-dependent stimuli. We detected abnormalities in the expression of photoreceptive melanopsin (OPN4). Furthermore, we identified alterations in the DNA methylation pathways throughout the retinohypothalamic tract terminals and links between the transcription factor Rev-Erbα and Fbxl3. The results of this study, primarily represent a contribution towards an understanding of electrophysiological and molecular phenotypic responses to external stimuli in the Afh model. Moreover, as DNA methylation has recently emerged as a new regulator of neuronal networks with important consequences for circadian behaviour, we discuss the impact of the Afh mutation on the epigenetic landscape of circadian biology.
Sections du résumé
BACKGROUND
DNA methylation has emerged as an important epigenetic regulator of brain processes, including circadian rhythms. However, how DNA methylation intervenes between environmental signals, such as light entrainment, and the transcriptional and translational molecular mechanisms of the cellular clock is currently unknown. Here, we studied the after-hours mice, which have a point mutation in the Fbxl3 gene and a lengthened circadian period.
METHODS
In this study, we used a combination of in vivo, ex vivo and in vitro approaches. We measured retinal responses in Afh animals and we have run reduced representation bisulphite sequencing (RRBS), pyrosequencing and gene expression analysis in a variety of brain tissues ex vivo. In vitro, we used primary neuronal cultures combined to micro electrode array (MEA) technology and gene expression.
RESULTS
We observed functional impairments in mutant neuronal networks, and a reduction in the retinal responses to light-dependent stimuli. We detected abnormalities in the expression of photoreceptive melanopsin (OPN4). Furthermore, we identified alterations in the DNA methylation pathways throughout the retinohypothalamic tract terminals and links between the transcription factor Rev-Erbα and Fbxl3.
CONCLUSIONS
The results of this study, primarily represent a contribution towards an understanding of electrophysiological and molecular phenotypic responses to external stimuli in the Afh model. Moreover, as DNA methylation has recently emerged as a new regulator of neuronal networks with important consequences for circadian behaviour, we discuss the impact of the Afh mutation on the epigenetic landscape of circadian biology.
Identifiants
pubmed: 33407878
doi: 10.1186/s13072-020-00373-5
pii: 10.1186/s13072-020-00373-5
pmc: PMC7789812
doi:
Substances chimiques
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1Références
Dev Dyn. 2005 Nov;234(3):718-25
pubmed: 15973738
PLoS One. 2014 Sep 24;9(9):e107400
pubmed: 25250616
Eye (Lond). 2016 Feb;30(2):247-54
pubmed: 26768919
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Transl Psychiatry. 2014 Jan 21;4:e347
pubmed: 24448209
J Comput Neurosci. 2010 Aug;29(1-2):213-229
pubmed: 19669401
Cell Mol Life Sci. 2012 Oct;69(19):3329-39
pubmed: 22627494
PLoS One. 2012;7(6):e38263
pubmed: 22719873
Nature. 2012 Nov 22;491(7425):594-8
pubmed: 23151476
Neuron. 2017 Jan 18;93(2):441-450
pubmed: 28065650
J Clin Neurosci. 2004 Apr;11(3):227-35
pubmed: 14975408
Hum Mol Genet. 2020 Jul 29;29(12):2051-2064
pubmed: 32426821
Science. 2008 May 30;320(5880):1224-9
pubmed: 18511691
Cell Transplant. 2015;24(4):721-35
pubmed: 25413246
J Comp Physiol. 1981 Dec 1;143(4):527-539
pubmed: 25309022
Chronobiol Int. 2018 Jul;35(7):920-932
pubmed: 29509082
Neural Netw. 2010 Aug;23(6):685-97
pubmed: 20554151
J Physiol. 2013 Feb 15;591(4):1063-80
pubmed: 23207594
Biotechniques. 2013 Mar;54(3):141-53
pubmed: 23599922
Chronobiol Int. 2017;34(1):37-44
pubmed: 27690288
Genes Dev. 2011 May 15;25(10):1010-22
pubmed: 21576262
Cell Mol Life Sci. 2013 Sep;70(18):3435-47
pubmed: 23604021
Neuron. 2007 Mar 1;53(5):677-87
pubmed: 17329208
Nature. 2008 Aug 7;454(7205):766-70
pubmed: 18600261
J Comput Neurosci. 2008 Jun;24(3):346-57
pubmed: 18066657
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16651-6
pubmed: 24067648
Science. 2002 Feb 8;295(5557):1065-70
pubmed: 11834834
ACS Chem Biol. 2010 Oct 15;5(10):925-32
pubmed: 20677822
PLoS Biol. 2010 Oct 12;8(10):e1000513
pubmed: 20967239
Bioinformatics. 2005 Jul 1;21(13):2933-42
pubmed: 15860560
Curr Biol. 2017 Feb 20;27(4):508-513
pubmed: 28162893
Genome Biol. 2017 Apr 11;18(1):68
pubmed: 28399939
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8689-94
pubmed: 20395551
J Biol Rhythms. 2018 Feb;33(1):84-98
pubmed: 29219034
Front Neuroeng. 2013 Nov 19;6:10
pubmed: 24312049
J Clin Invest. 2014 Apr;124(4):1468-82
pubmed: 24614104
Science. 2007 May 11;316(5826):897-900
pubmed: 17463252
FEBS J. 2015 Oct;282(19):3669-80
pubmed: 26185901
Nat Neurosci. 2011 Oct 30;14(12):1607-16
pubmed: 22037496
Nucleic Acids Res. 2004 Jan 29;32(2):598-610
pubmed: 14752048
J Neurosci. 2006 Aug 16;26(33):8465-76
pubmed: 16914671
Front Genet. 2016 Jun 17;7:110
pubmed: 27379160
Philos Trans R Soc Lond B Biol Sci. 2014 Jan 20;369(1637):20120471
pubmed: 24446504
Neuron. 2012 Apr 26;74(2):246-60
pubmed: 22542179
EMBO Rep. 2011 Jul 01;12(7):647-56
pubmed: 21660058
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4750-5
pubmed: 23471982
Methods Mol Biol. 2012;925:187-97
pubmed: 22907498
eNeuro. 2019 Nov 15;6(6):
pubmed: 31685676
Gen Comp Endocrinol. 2017 Mar 1;243:130-137
pubmed: 27916575
J Neurophysiol. 2007 Apr;97(4):2937-48
pubmed: 17287439
Chronobiol Int. 2017;34(8):1067-1082
pubmed: 28704069
Science. 2010 May 14;328(5980):916-9
pubmed: 20395474
Mol Biol Cell. 2009 Dec;20(23):4899-909
pubmed: 19812244
Science. 2002 Dec 13;298(5601):2213-6
pubmed: 12481141
Nat Genet. 2011 Jun 26;43(8):811-4
pubmed: 21706000
Neurobiol Aging. 2011 Mar;32(3):419-33
pubmed: 19356824
Sci Rep. 2017 Dec 19;7(1):17765
pubmed: 29259298
Nat Neurosci. 2014 Mar;17(3):377-82
pubmed: 24531307
Science. 2007 May 11;316(5826):900-4
pubmed: 17463251
Curr Biol. 2006 Feb 21;16(4):389-95
pubmed: 16488873
Bipolar Disord. 2013 Sep;15(6):694-700
pubmed: 23782472
Nat Protoc. 2007;2(9):2265-75
pubmed: 17853883
Neurosci Biobehav Rev. 2013 Mar;37(3):229-39
pubmed: 23286902
J Neurosci. 2017 Aug 16;37(33):7824-7836
pubmed: 28698388
PLoS Genet. 2010 Sep 23;6(9):e1001134
pubmed: 20885785
Bioinformatics. 2011 Jun 1;27(11):1571-2
pubmed: 21493656
J Biol Chem. 2009 Mar 6;284(10):6043-7
pubmed: 19117947
PLoS Genet. 2014 Nov 06;10(11):e1004792
pubmed: 25375876
J Neurosci. 2016 Feb 17;36(7):2086-100
pubmed: 26888921
Cold Spring Harb Perspect Biol. 2017 Jan 3;9(1):
pubmed: 28049647
Science. 2005 Aug 26;309(5739):1390-4
pubmed: 16109848
Genes Dev. 2002 Jan 1;16(1):6-21
pubmed: 11782440
J Cell Sci. 2009 Jan 1;122(Pt 1):5-11
pubmed: 19092055